UCFA
IMMX icon

United Capital Financial Advisors’s Immix Biopharma IMMX Stock Holding History

United Capital Financial Advisors’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$729K Hold
70,682
– – ﹤0.01% 942
2026
Q1 		$644K Hold
70,682
– – ﹤0.01% 946
2025
Q4 		$370K Hold
70,682
– – ﹤0.01% 1091
2025
Q3 		$148K Buy
+70,682
New +$170K ﹤0.01% 1183

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

United Capital Financial Advisors's IMMX Position: Q2 2026 in Review

United Capital Financial Advisors held its Immix Biopharma (IMMX) position steady in Q2 2026 at 70,682 shares worth $729K. The position accounts for ﹤0.01% of the portfolio, ranked #942.

United Capital Financial Advisors first reported a position in IMMX in Q3 2025 and has held it in 4 quarters since. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • United Capital Financial Advisors held 70,682 shares of Immix Biopharma worth $729K as of Q2 2026.
  • United Capital Financial Advisors left its Immix Biopharma share count unchanged in Q2 2026.
  • Immix Biopharma made up ﹤0.01% of United Capital Financial Advisors's portfolio in Q2 2026, its #942 holding.
  • United Capital Financial Advisors first reported a position in Immix Biopharma in Q3 2025 and has held it in 4 quarters since.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.